ALPS Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-20,338
| Closed | -$1.62M | – | 939 |
|
|
2021
Q3 | $1.62M | Sell |
20,338
-1,406
| -6% | -$112K | 0.02% | 340 |
|
|
2021
Q2 | $2.12M | Sell |
21,744
-6,235
| -22% | -$607K | 0.02% | 319 |
|
|
2021
Q1 | $3.27M | Buy |
27,979
+75
| +0.3% | +$8.77K | 0.03% | 207 |
|
|
2020
Q4 | $3.1M | Buy |
27,904
+8,222
| +42% | +$914K | 0.03% | 210 |
|
|
2020
Q3 | $2.34M | Sell |
19,682
-1,365
| -6% | -$162K | 0.03% | 215 |
|
|
2020
Q2 | $2.38M | Sell |
21,047
-7,006
| -25% | -$794K | 0.03% | 221 |
|
|
2020
Q1 | $1.87M | Sell |
28,053
-2,967
| -10% | -$198K | 0.03% | 219 |
|
|
2019
Q4 | $2.83M | Buy |
31,020
+263
| +0.9% | +$24K | 0.02% | 199 |
|
|
2019
Q3 | $2.65M | Sell |
30,757
-1,516
| -5% | -$131K | 0.02% | 192 |
|
|
2019
Q2 | $3.38M | Sell |
32,273
-4,907
| -13% | -$514K | 0.03% | 178 |
|
|
2019
Q1 | $4.66M | Buy |
37,180
+1,608
| +5% | +$201K | 0.03% | 173 |
|
|
2018
Q4 | $4.01M | Buy |
35,572
+8,378
| +31% | +$944K | 0.03% | 171 |
|
|
2018
Q3 | $5.82M | Buy |
27,194
+6,615
| +32% | +$1.42M | 0.04% | 152 |
|
|
2018
Q2 | $5.76M | Buy |
20,579
+1,800
| +10% | +$503K | 0.04% | 161 |
|
|
2018
Q1 | $2.19M | Buy |
18,779
+4,932
| +36% | +$576K | 0.02% | 206 |
|
|
2017
Q4 | $1.27M | Buy |
+13,847
| New | +$1.27M | 0.01% | 224 |
|